DaVita Inc. specializes in providing dialysis services. Net sales break down by activity as follows: - supply of dialysis services (95.7%): hemodialysis and peritoneal dialysis services for patients suffering from chronic renal failure. At the end of 2024, services are insured through 2,657 dialysis centers serving nearly 200,800 patients in the United States, and through 509 dialysis centers serving nearly 80,300 patients abroad; - other (4.3%).

Employees

76,000

Sector

Healthcare Facilities & Services

Calendar

Feb. 17 - Q4 2025 Earnings Release (Projected)

More about the company

Quotes

Date	Price	Change	Volume
25-12-12	121.35 $	+0.85%	775,882
25-12-11	120.33 $	+1.39%	1,045,590
25-12-10	118.68 $	+1.72%	969,423
25-12-09	116.67 $	-0.32%	573,742
25-12-08	117.05 $	-0.29%	688,125

Delayed Quote Nyse, December 12, 2025 at 04:00 pm EST

More quotes

Income Statement and Estimates

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

121.35USD

Average target price

144.50USD

Spread / Average Target

+19.08%

Consensus

EPS Estimates

Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar

Market Closed - Nyse Other stock markets 04:00:02 2025-12-12 pm EST			5-day change	1st Jan Change
121.35 ^USD	+0.85%		+3.37%	-18.86%

Dec. 11	Davita Inc. Appoints Stephanie Hendrickson as Chief People Officer and Steve Phillips as Chief Strategy Officer, Effective December 11, 2025	CI
Nov. 25	DaVita Inc enters eighth amendment to credit agreement dated August 12, 2019 - SEC filing	RE

Capitalization	8.57B 7.3B 6.82B 6.41B 11.81B 776B 12.9B 79.58B 30.87B 366B 32.15B 31.47B 1,335B	P/E ratio 2025 *	12.1x	P/E ratio 2026 *	10.3x
Enterprise value	18.69B 15.92B 14.87B 13.99B 25.76B 1,693B 28.14B 174B 67.33B 798B 70.12B 68.64B 2,911B	EV / Sales 2025 *	1.38x	EV / Sales 2026 *	1.34x
Free-Float	46.97%	Yield 2025 *	-	Yield 2026 *	-

Dec. 11	Davita Inc. Appoints Stephanie Hendrickson as Chief People Officer and Steve Phillips as Chief Strategy Officer, Effective December 11, 2025	CI
Nov. 25	DaVita Inc enters eighth amendment to credit agreement dated August 12, 2019 - SEC filing	RE
Nov. 25	DaVita Inc. Enters into an Eighth Amendment to Credit Agreement	CI
Nov. 17	DaVita Inc. Presents at 7th Annual Wolfe Research Healthcare Conference, Nov-17-2025 11:20 AM
Nov. 04	DaVita Marks 25 Years of Innovation with Breakthrough Kidney Care Research at ASN Kidney Week 2025	CI
Nov. 03	TD Cowen Adjusts Price Target on DaVita to $133 From $154	MT
Oct. 30	Barclays Adjusts Price Target on DaVita to $143 From $149	MT
Oct. 30	Deutsche Bank Adjusts Price Target on DaVita to $126 From $137	MT
Oct. 31	DaVita Inc., Q3 2025 Earnings Call, Oct 29, 2025
Oct. 29	Berkshire Hathaway sells 401,514 DaVita shares, still owns about 31.76 million	RE
Oct. 29	DaVita Q3 Adjusted Earnings Fall, Revenue Rises	MT
Oct. 29	DaVita misses quarterly profit estimates on rising costs, lower volumes	RE
Oct. 29	DaVita Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI

Nov. 03	TD Cowen Adjusts Price Target on DaVita to $133 From $154	MT
Oct. 30	Barclays Adjusts Price Target on DaVita to $143 From $149	MT
Oct. 30	Deutsche Bank Adjusts Price Target on DaVita to $126 From $137	MT
Oct. 08	Barclays Adjusts Price Target on DaVita to $149 From $160	MT
Aug. 08	Truist Adjusts Price Target on DaVita to $148 From $164, Maintains Hold Rating	MT

DaVita Inc. Stock

Equities

DVA

US23918K1088

Healthcare Facilities & Services

Valuation: DaVita Inc.

Chart: DaVita Inc.

Latest news: DaVita Inc.

Last Transcript: DaVita Inc.

Analysts' recommendations: DaVita Inc.

Press Releases: DaVita Inc.

News in other languages: DaVita Inc.

Quotes and Performance

Course Extremes

Managers and Directors: DaVita Inc.

ETFs: DaVita Inc.

Other Healthcare Facilities & Services

Financials

Company Profile

Quotes

Income Statement and Estimates

Analysts' Consensus

Quarterly revenue - Rate of surprise

Dec. 11	DaVita Names New Leaders to Accelerate Care Transformation	PR
Nov. 14	DaVita Inc. to Participate in Fireside Chat with Wolfe Research	PR
Nov. 13	DaVita Launches 'Caring Across Communities' to Support California Nonprofits	AQ
Nov. 04	DaVita Marks 25 Years of Innovation with Breakthrough Kidney Care Research at ASN Kidney Week 2025	PR
Oct. 29	DaVita Inc. 3rd Quarter 2025 Results	PR

Aug. 21	Bourse : Eiffage engrange, Meta freine ses embauches IA, Sony relève le prix de la PS5
Aug. 21	Les investisseurs astiquent leurs boucliers
May. 12	Bourse : fumée (presque) blanche chez Stellantis, Danone investit aux USA, Valneva doit revoir sa copie
May. 12	Tout est négociable !
Apr. 14	Aktien New York: Erholung wird zäher - Zölle bleiben im Fokus

1 day	+0.85%
1 week	+3.37%
Current month	+1.40%
1 month	-0.16%
3 months	-8.88%
6 months	-10.85%
Current year	-18.86%

1 week	116	122.61
1 month	113.97	122.61
Current year	113.97	179.6
1 year	113.97	179.6
3 years	70.8	179.6
5 years	65.28	179.6
10 years	43.4	179.6

Manager	Title	Age	Since
Javier Rodriguez CEO	Chief Executive Officer	54	2019-05-31
Joel Ackerman DFI	Director of Finance/CFO	60	2017-02-26
David Maughan COO	Chief Operating Officer	48	2024-09-14

Director	Title	Age	Since
Pamela Arway CHM	Chairman	71	2020-05-31
Barbara Desoer BRD	Director/Board Member	72	2015-10-07
Javier Rodriguez BRD	Director/Board Member	54	2019-05-31

Name	Weight	AuM	Varia. Jan 1.	Investor
AGF U.S. MARKET NEUTRAL ANTI-BETA FUND - USD	15.19%	303 M€	-21.05%	-
FIRST TRUST ALPHADEX U.S. HEALTH CARE SECTOR INDEX ETF - CAD HEDGED	0.93%	2 M€	+9.31%	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
DAVITA INC.	+0.85%	+3.37%	-20.55%	+62.43%	8.57B
HCA HEALTHCARE, INC.	+0.50%	-0.40%	+54.42%	+98.11%	111B
CVS HEALTH CORPORATION	-1.74%	+5.01%	+60.87%	-21.12%	101B
FRESENIUS SE & CO. KGAA	+3.21%	+2.58%	+40.34%	+89.53%	31.44B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	-1.78%	-1.02%	-14.68%	+11.04%	24.07B
LABCORP HOLDINGS INC.	-0.21%	+2.24%	+13.87%	+14.55%	21.9B
QUEST DIAGNOSTICS INCORPORATED	+0.55%	+0.03%	+17.78%	+20.81%	20.31B
REDE D'OR SÃO LUIZ S.A.	+1.65%	+2.04%	+67.79%	+76.68%	18.33B
TENET HEALTHCARE CORPORATION	+0.85%	-5.05%	+45.86%	+334.71%	17.52B
UNIVERSAL HEALTH SERVICES, INC.	-0.88%	-3.67%	+18.78%	+70.14%	13.91B
Average	+0.30%	+0.21%	+28.45%	+75.69%	36.75B
Weighted average by Cap.	-0.04%	+1.09%	+43.18%	+58.04%

	2025 *	2026 *
Net sales	13.51B 11.51B 10.75B 10.12B 18.63B 1,224B 20.35B 126B 48.69B 577B 50.71B 49.64B 2,105B	13.96B 11.89B 11.11B 10.45B 19.24B 1,264B 21.01B 130B 50.28B 596B 52.36B 51.26B 2,174B
Net income	781M 665M 621M 585M 1.08B 70.73B 1.18B 7.25B 2.81B 33.34B 2.93B 2.87B 122B	848M 723M 675M 635M 1.17B 76.83B 1.28B 7.88B 3.06B 36.21B 3.18B 3.12B 132B
Net Debt	10.12B 8.62B 8.05B 7.58B 13.95B 917B 15.24B 93.99B 36.46B 432B 37.97B 37.17B 1,576B	10.1B 8.6B 8.04B 7.56B 13.92B 915B 15.21B 93.8B 36.38B 431B 37.89B 37.09B 1,573B